期刊文献+

高滴度腺病毒介导的绿色荧光蛋白和反义血管内皮生长因子165cDNA的制备 被引量:2

Preparation of high-titer Ad-GFP and Ad-aVEGF_(165)cDNA
下载PDF
导出
摘要 目的:制备高滴度腺病毒介导的绿色荧光蛋白(Ad-GFP)和腺病毒介导的反义血管内皮生长因子165(Ad-aVEGF_(165))cDNA。方法:人胚肾293腺病毒包装细胞转染第3代Ad-GFP和Ad-aVEGF_(165)cDNA后,反复冻融293细胞,提取腺病毒悬液,用氯化铯梯度离心法纯化腺病毒,在荧光显微镜下测定Ad-GFP的滴度,用空斑法测定Ad-aVEGF_(165)cDNA的滴度。结果:获取了实验所需的第4代腺病毒液,Ad-GFP的滴度为9.5×109efu/ml,Ad-aVEGF_(165)cDNA的滴度为1.2×1010pfu/ml。结论:成功制备了高滴度的Ad-GFP和Ad-aVEGF_(165)cDNA。 Aim: To obtain high titer of adenovirus mediated GFP(Ad-GFP) and antisense-VEGF165 (Ad-aVEGF165 )cDNA. Methods:Ad-GFP and Ad-aVEGF165 cDNA were transfected into 293 cells, then adenovirus suspension was extracted by freezing and thawing 293 cells repeatedly and purified by CsCl2 gradient centrifugation and titrated with fluorescence microscopy or cytopathetic effect (CPE). Results- Enough fourth adenovirus suspension was harvested. The titers of Ad- GFP and Ad-aVEGF cDNA were 9.5 × 10^9 efu/ml and 1.2 × 10^10 pfu/ml, respectively. Conclusion: Ad-GFP and Ad- aVEGF165 cDNA of high titers were obtained successfully.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2006年第1期127-129,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 血管内皮生长因子 基困治疗 腺病毒载体 滴度 VEGF gene therapy adenovirus vector titer
  • 相关文献

参考文献6

二级参考文献22

  • 1司徒振强 吴军正主编.细胞培养:第1版[M].西安:世界图书出版公司,1996.186~187.
  • 2[1]Cole SPC, Bhardwa JG, Gerlach.JH, et al. Overexpression of transporter gene in a multidrug-resistant human lung cancer cell line. Science, 1992; 258(5088): 1650
  • 3[2]Hipfner DR, Deeley RG, Coloe SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta, 1999;1461(2): 359
  • 4[3]Roelofsen H, Vos TA, Schippers IJ, et al. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte derived cells. Gastroenterology, 1997; 112(2): 511
  • 5[5]Carter G, Lemoine NR. Antisense technology for cancer therapy: does it make sense?. Br J Cancer, 1993; 67(5): 869
  • 6[6]He TC, Zhou S, Da Costa LT, et al. A simplified system for generating recombinant adenovirus. Proc Natl Acad Sci USA, 1998; 95(5): 2509
  • 7[7]Inoue H, Nojima H, Okayama H. High efficiency transformation of Escherichia coli with plasmids. Gene, 1990; 96(1): 23
  • 8[8]Itsubo M, Ishikawa T, Toda G, et al. Immunohistochemic study of expression and cellular localization of the multidrug resistance gene product p-glycoprotein in primary liver carcinoma. Cancer, 1994; 73(2): 298
  • 9[9]Lai EC, Choi TK, Cheng CH, et al. Doxorubicin for unresectable hepatocellular carcinoma, A prospective study on the addition of verapami. Cancer, 1990; 66(8): 1685
  • 10[10]Bradshaw DM, Arceci RJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol, 1998; 16(11): 3674

共引文献4

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部